Posted On: October 31, 2018
The Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG) is the leading body representing the interests of Australian and New Zealand children and adolescents with blood diseases and cancer.
ANZCHOG’s vision is to ensure that all children and adolescents with cancer and associated blood diseases are provided with the highest quality, evidence-based care to ensure optimal outcomes in terms of survivorship and quality of life.
The research and clinical trials conducted by ANZCHOG are vital for improvements in the cure, treatment and care of Australian and New Zealand children with cancer. ANZCHOG is partnering with the world’s leading children’s cancer clinical trial groups to ensure that Australian and New Zealand children have access to the best available treatments.
Meet the Chair of ANZCHOG
Dr Chris Fraser
Dr Chris Fraser is a paediatric oncologist at the Queensland Children’s Hospital in Brisbane. He has been a member of the ANZCHOG Executive Committee since 2010 and the Chair of the Committee since 2014.
Dr Fraser completed his paediatric oncology training at the Royal Children’s Hospital (Melbourne) between 2001-2004 before travelling to the University of Minnesota (Minneapolis, USA) to complete a fellowship in paediatric bone marrow transplantation, and then returned to Royal Children’s Hospital (Melbourne) as a consultant oncologist in 2006. In 2008, he took up a role as the Director of the Blood and Marrow Transplant Program at the Royal Children’s Hospital in Brisbane and has continued that role since the move of Brisbane paediatric oncology services to the Lady Cilento Children’s Hospital in November 2014. He has served as the Chair of the ANZCHOG BMT sub-group and on numerous other national and international committees in the fields of paediatric oncology and bone marrow transplantation.
During his tenure as the Chair of ANZCHOG, Dr Fraser has focussed on developing the sustainability of the organisation as a national clinical trials organisation.
Read more: International clinical trials support.
Donate to research and help find more effective treatments for kids with cancer.